'Collateral damage' from normal cell function may cause mutations that play a role in cancer

by Wellcome Trust Sanger InstituteSpatial distribution of APOBEC-positive crypts. APOBEC-positive crypts and their surrounding crypts before microdissection with their SBS mutational spectrums. S

Updated on: February 18,2024

'Collateral damage' from normal cell function may cause mutations that play a role in cancer

by Wellcome Trust Sanger InstituteSpatial distribution of APOBEC-positive crypts. APOBEC-positive crypts and their surrounding crypts before microdissection with their SBS mutational spectrums. S

Updated on:February 18,2024

Researchers find new treatment for prostate cancer

by University of Oslo“We think that what we found is really exciting", says Professor Fahri Saatcioglu. Credit: University of OsloProfessor Fahri Saatcioglu at University of Oslo's Depar

Updated on: June 19,2024

Researchers find new treatment for prostate cancer

by University of Oslo“We think that what we found is really exciting", says Professor Fahri Saatcioglu. Credit: University of OsloProfessor Fahri Saatcioglu at University of Oslo's Depar

Updated on:June 19,2024

Inhibitor shows lasting structural integrity and long terminal half-life in tumor tissue

by Vall d'Hebron Institute of OncologyLaura Soucek, co-Director of Preclinical and Translational Research at VHIO, Chief Executive Officer of Peptomyc, and an ICREA Research Professor. Credit: VHI

Updated on: February 18,2024

Inhibitor shows lasting structural integrity and long terminal half-life in tumor tissue

by Vall d'Hebron Institute of OncologyLaura Soucek, co-Director of Preclinical and Translational Research at VHIO, Chief Executive Officer of Peptomyc, and an ICREA Research Professor. Credit: VHI

Updated on:February 18,2024

'Dead zone' within tumor promotes cancer spread, helped by a protein secreted by cancer cells

by Diana Mapes, Fred Hutchinson Cancer CenterFred Hutch's Ami Yamamoto, foreground, at work in the lab of Dr. Kevin Cheung (seen in background). Yamamoto's investigation of the necrotic core o

Updated on: February 18,2024

'Dead zone' within tumor promotes cancer spread, helped by a protein secreted by cancer cells

by Diana Mapes, Fred Hutchinson Cancer CenterFred Hutch's Ami Yamamoto, foreground, at work in the lab of Dr. Kevin Cheung (seen in background). Yamamoto's investigation of the necrotic core o

Updated on:February 18,2024

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on: January 23,2024

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on:January 23,2024

Study finds large gap in breast cancer treatment recommendations for patients aged 70 vs. 69

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainAge-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic

Updated on: January 23,2024

Study finds large gap in breast cancer treatment recommendations for patients aged 70 vs. 69

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainAge-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic

Updated on:January 23,2024

A researcher's prescription for better health care: A dose of humility for doctors, nurses and clinicians

by Barret Michalec,The ConversationCredit: Pixabay/CC0 Public DomainBetter health care for patients begins with humility—a term not often associated with medicine.I witnessed displays ofhu

Updated on: June 04,2024

A researcher's prescription for better health care: A dose of humility for doctors, nurses and clinicians

by Barret Michalec,The ConversationCredit: Pixabay/CC0 Public DomainBetter health care for patients begins with humility—a term not often associated with medicine.I witnessed displays ofhu

Updated on:June 04,2024

New tool charts differentiation landscape of acute myeloid leukemia

by Center for Genomic RegulationGraphical Abstract. Credit:Cell Stem Cell(2023). DOI: 10.1016/j.stem.2023.04.001Researchers have developed a new method to distinguish between cancerous and

Updated on: January 13,2024

New tool charts differentiation landscape of acute myeloid leukemia

by Center for Genomic RegulationGraphical Abstract. Credit:Cell Stem Cell(2023). DOI: 10.1016/j.stem.2023.04.001Researchers have developed a new method to distinguish between cancerous and

Updated on:January 13,2024

New cancer 'tracer' promises to detect more tumors earlier

by Ramona Czakert Franson,University of AlbertaCredit: Pixabay/CC0 Public DomainFor people waiting for imaging tests to diagnose neuroendocrine cancer, time is of the essence. Now, thanks to res

Updated on: January 11,2024

New cancer 'tracer' promises to detect more tumors earlier

by Ramona Czakert Franson,University of AlbertaCredit: Pixabay/CC0 Public DomainFor people waiting for imaging tests to diagnose neuroendocrine cancer, time is of the essence. Now, thanks to res

Updated on:January 11,2024

Researchers invent a new class of AI to improve cancer research and treatments

by Colette Gallagher,Mayo ClinicCredit: Mayo ClinicMayo Clinic researchers recently invented a new class of artificial intelligence (AI) algorithms called hypothesis-driven AI that are a signifi

Updated on: March 20,2024

Researchers invent a new class of AI to improve cancer research and treatments

by Colette Gallagher,Mayo ClinicCredit: Mayo ClinicMayo Clinic researchers recently invented a new class of artificial intelligence (AI) algorithms called hypothesis-driven AI that are a signifi

Updated on:March 20,2024

Access to genomic medicine illustrates precision medicine's delicate future

byOsaka UniversityTest Availability of Multigene Panel Tests in Japan and SwitzerlandCC BY, Nakasato K, Manz C and Kato K (2024) Access, autonomy, and affordability: ethical and human rights iss

Updated on: April 28,2024

Access to genomic medicine illustrates precision medicine's delicate future

byOsaka UniversityTest Availability of Multigene Panel Tests in Japan and SwitzerlandCC BY, Nakasato K, Manz C and Kato K (2024) Access, autonomy, and affordability: ethical and human rights iss

Updated on:April 28,2024

Only one in five Indonesian women are aware of cervical cancer screening

by European Society for Medical OncologyCredit: European Society for Medical OncologyJust one in five Indonesian women are aware of cervical cancer screening, according to a study presented at th

Updated on: April 10,2024

Only one in five Indonesian women are aware of cervical cancer screening

by European Society for Medical OncologyCredit: European Society for Medical OncologyJust one in five Indonesian women are aware of cervical cancer screening, according to a study presented at th

Updated on:April 10,2024